President and Chief Executive Officer
Emory has over 32 years of experience in the healthcare, consumer electronics and data communications industries. He joined Intuity Medical as the President and Chief Executive Officer in September, 2008. Prior to Intuity Medical, Emory served as President and Chief Executive Officer of Adeza Biomedical, a public company focusing on women's reproductive healthcare. At Adeza, Emory lead the company to a successful IPO in 2004 and eventual acquisition by Cytyc in 2007. Before Adeza, Emory served as Executive Vice President and Chief Operating Officer of Indesys, a data communications company, which he co-founded in 1984. Previously, he held the position of Director of Finance for Atari, in the Consumer Electronics Division.
Chief Commercial Officer, Senior Vice President – Sales and Marketing
Tim joined Intuity Medical in February 2018 with more than 26 years of experience in the pharmaceutical industry, serving in numerous roles in both the prescription (Rx) and over-the-counter (OTC) space. Prior to Intuity, Tim served as Vice President of Consumer Health for AmerisourceBergen, a leading global pharmaceutical sourcing and distribution services company. serving in that role since October 2011. Before AmerisourceBergen, Tim spent more than nine years operating in several senior level sales roles for Adams Respiratory Therapeutics as part of a team responsible for the commercialization of Mucinex®. Adams was acquired by Reckitt Benckiser Group in 2008. Previously, Tim worked for various pharmaceutical manufacturers in sales and marketing leadership roles.
Senior Vice President of Corporate Development and Finance
Robb Hesley has over 21 years in the medical device and pharmaceutical industries. He joined Intuity Medical in 2011 as Vice President of Corporate Development and Finance and brings extensive experience in product development, commercialization and financing of medical device companies. Serving as VP of Business Development at Hologic Inc., Robb managed all aspects of the FDA approval process for a New Drug Application (NDA), resulting in the sale of the drug for $200MM. Prior to Hologic, Robb was VP of Business Development at Adeza where he was instrumental in the company’s successful IPO and ultimate acquisition by Cytyc Corporation. Robb also held roles as VP of Business Development and R&D at Metrika, Inc., and Director of Business Development at Metra Biosystems.
Chief Manufacturing Officer, Senior Vice President of Operations – Product Development and Quality
Pat has over 20 years of experience in the medical device industry. He served previously as COO of Synaptive Medical, Insulet, and Alphatec Spine. Pat also held both commercial and operational executive positions with Abbott Vascular/Guidant, with roles based in Ireland, California, Argentina, and China. He served nearly 15 years on active duty as an officer in the US Navy.